Y7Y-29637-56370
3 vaccinations
3 coded responses
18 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 900 / CA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Cough — Feeling: FairFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities2 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-14
-
2021-01-19
Survey response — day 14, dose 2MedDRA: Angioedema, Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: I have had two episode of an allergic reaction >1week after my vaccination. Ive had minor allergic reactions in the past due to unknown allergen. I had mild angioedema of the upper lip during my 2nd episode which has never occurred before.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — day 21, dose 2MedDRA: Angioedema, Urticaria — Feeling: FairFree text: I have had recurrent episodes of urticaria/angioedema. This time it was related to delayed pressure angioedema due to wearing double layer clothing. It also affected my eyelid though after I rubbed my eye.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2022-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | priority 2/3 | |
| 2021-01-06 | priority 2/3 |
Free text
Release 1 — day 14, dose 1
Symptoms: Cough
Release 2 — day 14, dose 2
Symptoms: I have had two episode of an allergic reaction >1week after my vaccination. Ive had minor allergic reactions in the past due to unknown allergen. I had mild angioedema of the upper lip during my 2nd episode which has never occurred before.
Release 2 — day 21, dose 2
Symptoms: I have had recurrent episodes of urticaria/angioedema. This time it was related to delayed pressure angioedema due to wearing double layer clothing. It also affected my eyelid though after I rubbed my eye.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angioedema | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release